Global Rise of Multidrug Resistant Tuberculosis Threatens to Derail Decades of Progress

“TB exists on an epic scale in India, and cases of multidrug resistant TB are an increasing concern. Access to drugs to treat TB, including drug resistant TB is a major concern. Despite some small scale programmes for compassionate use of new life-saving drugs such as bedaquiline and delamanid, there is no widespread access in India meaning these drugs remain unavailable to patients who need them most. Many patients at risk of transmission, or who need palliative care, live in the community because hospitals are full. In addition to new drugs, we need to ensure that patients with incurable disease are treated with dignity and afforded the care they need,” says Dr Zarir Udwadia, Hinduja Hospital & Research Center, Mumbai, India and co-author of a new report pblished in The Lancet Respiratory Medicine on World TB day. The report is being launched at a conference at the University of Cape Town, South Africa, co-funded by the South African Medical Research Council and the South African Thoracic Society.

TB kills more people each year than any other infectious disease, including HIV/AIDS. In 2015, TB was estimated to have killed 1.8 million people. Six countries account for 60% of the total number of …

To read more subscribe
Show More

Related Articles

Leave a Reply